1. Home
  2. List
Reference Patent

Reference - List

  • 69 Hits
  • Search Condition : Filter (MeSH = Ovarian Neoplasms / pathology)
Species Resource Title
Human and Animal Cells JHOS-4(RCB1678) LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.
Human and Animal Cells JHOC-5(RCB1520) , JHOC-9(RCB2226) MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
Human and Animal Cells KGN(RCB1154) Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In Vitro.
Human and Animal Cells KGN(RCB1154) Estradiol promotes cell survival and induces Greb1 expression in granulosa cell tumors of the ovary through an ERα-dependent mechanism.
Human and Animal Cells JHOC-5(RCB1520) Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival.
Human and Animal Cells NIH:OVCAR-3(RCB2135) , OVK18(RCB1903) Sensitive β-galactosidase-targeting fluorescence probe for visualizing small peritoneal metastatic tumours in vivo.
Human and Animal Cells JHOC-5(RCB1520) , JHOC-7(RCB1688) , JHOC-8(RCB1723) , JHOC-9(RCB2226) Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix.
Human and Animal Cells JHOS-2(RCB1521) , JHOC-5(RCB1520) CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.
Human and Animal Cells OV2944-HM-1(RCB1483) Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells.
Human and Animal Cells KGN(RCB1154) Molecular manipulation of keratin 8/18 intermediate filaments: modulators of FAS-mediated death signaling in human ovarian granulosa tumor cells.
Human and Animal Cells KGN(RCB1154) Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells.
Human and Animal Cells HHUA(RCB0658) Growth-inhibitory signals by activin A do not affect anticancer drug-sensitivity and acquired multi-drug-resistance in human ovarian endometrioid adenocarcinoma OVK-18 cells.
Human and Animal Cells HHUA(RCB0658) Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
Human and Animal Cells NIH:OVCAR-3(RCB2135) Sulfated glycosaminoglycans mediate prion-like behavior of p53 aggregates.
Human and Animal Cells HHUA(RCB0658) Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
Human and Animal Cells JHOS-2(RCB1521) , JHOS-4(RCB1678) Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancer.
Human and Animal Cells JHOC-7(RCB1688) , JHOC-9(RCB2226) Effect of murine double-minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys.
Human and Animal Cells OVK18(RCB1903) GEP oncogene promotes cell proliferation through YAP activation in ovarian cancer.
Human and Animal Cells JHOS-2(RCB1521) TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells.
Human and Animal Cells JHOC-5(RCB1520) , JHOC-9(RCB2226) High Expression of p21 as a Potential Therapeutic Target in Ovarian Clear-cell Carcinoma.